Tiraje Tuncer1, Erdal Gilgil2, Cahit Kaçar1, Yeşim Kurtaiş3, Şehim Kutlay3, Bülent Bütün1, Peyman Yalçin3, Ülkü Akarirmak4, Lale Altan5, Füsun Ardiç6, Özge Ardiçoğlu7, Zuhal Altay8, Ferhan Cantürk9, Lale Cerrahoğlu10, Remzi Çevik11, Hüseyin Demir12, Berrin Durmaz13, Nigar Dursun14, Tuncay Duruöz15, Canan Erdoğan16, Deniz Evcik17, Savaş Gürsoy18, Sami Hizmetli19, Ece Kaptanoğlu19, Önder Kayhan15, Mehmet Kirnap12, Siranuş Kokino20, Erkan Kozanoğlu21, Banu Kuran22, Kemal Nas23, Sema Öncel24, Dilşad Sindel25, Sevim Orkun26, Tunay Sarpel21, Serpil Savaş27, Ömer Faruk Şendur28, Kazım Şenel29, Hatice Uğurlu30, Kaan Uzunca31, İbrahim Tekeoğlu23, Francis Guillemin32. 1. Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Akdeniz University, School of Medicine, Antalya, Turkey. 2. Private Rheumatologist, Antalya, Turkey. 3. Department of Physical Medicine and Rehabilitation, Ankara University, School of Medicine, Ankara, Turkey. 4. Department of Physical Medicine and Rehabilitation, Istanbul University, School of Cerrahpaşa Medicine, Istanbul, Turkey. 5. Department of Physical Medicine and Rehabilitation, Uludağ University, School of Medicine, Bursa, Turkey. 6. Department of Physical Medicine and Rehabilitation, Pamukkale University, School of Medicine, Denizli, Turkey. 7. Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Yıldırım Beyazıt University, School of Medicine, Ankara, Turkey. 8. Department of Physical Medicine and Rehabilitation, İnönü University, School of Medicine, Malatya, Turkey. 9. Department of Physical Medicine and Rehabilitation, Medilife Health Group, Istanbul, Turkey. 10. Department of Physical Medicine and Rehabilitation, Celal Bayar University, School of Medicine, Manisa, Turkey. 11. Department of Physical Medicine and Rehabilitation, Dicle University, School of Medicine, Diyarbakır, Turkey. 12. Department of Physical Medicine and Rehabilitation, Erciyes University, School of Medicine, Kayseri, Turkey. 13. Department of Physical Medicine and Rehabilitation, Ege University, School of Medicine, Izmir, Turkey. 14. Department of Physical Medicine and Rehabilitation, Kocaeli University, School of Medicine, Kocaeli, Turkey. 15. Department of Physical Medicine and Rehabilitation, Marmara University, School of Medicine, Istanbul, Turkey. 16. Department of Physical Medicine and Rehabilitation, Mersin University, School of Medicine, Mersin, Turkey. 17. Department of Physical Medicine and Rehabilitation, Ufuk University, School of Medicine, Ankara, Turkey. 18. Department of Physical Medicine and Rehabilitation, Gaziantep University, School of Medicine, Gaziantep, Turkey. 19. Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Cumhuriyet University, School of Medicine, Sivas, Turkey. 20. Department of Physical Medicine and Rehabilitation, Trakya University, School of Medicine (Deceased), Edirne, Turkey. 21. Department of Physical Medicine and Rehabilitation, Çukurova University, School of Medicine, Adana, Turkey. 22. Department of Physical Medicine and Rehabilitation, Şişli Etfal Hamidiye Education and Research Hospital, Istanbul, Turkey. 23. Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Sakarya University, School of Medicine, Sakarya, Turkey. 24. Department of Physical Medicine and Rehabilitation, Dokuz Eylül University, School of Medicine, İzmir, Turkey. 25. Department of Physical Medicine and Rehabilitation, Istanbul University, School of Medicine, Istanbul, Turkey. 26. Department of Physical Medicine and Rehabilitation, Beyazpınar Physical Therapy and Rehabilitation Center, Ankara, Turkey. 27. Department of Physical Medicine and Rehabilitation, Süleyman Demirel University, School of Medicine, Isparta, Turkey. 28. Department of Physical Medicine and Rehabilitation, Adnan Menderes University, School of Medicine, Aydın, Turkey. 29. Department of Physical Medicine and Rehabilitation, Atatürk University, School of Medicine (Deceased), Erzurum, Turkey. 30. Department of Physical Medicine and Rehabilitation, Necmettin Erbakan University, School of Medicine, Konya, Turkey. 31. Department of Physical Medicine and Rehabilitation, Medikent Hospital, Kırklareli, Turkey. 32. University of Lorraine, Faculté de Médecine, Directeur EA 4360 APEMAC, Nancy, France.
Abstract
OBJECTIVES: This study aims to estimate the prevalence of rheumatoid arthritis (RA) and spondyloarthritis (SpA) in Turkey using the same telephone questionnaire developed for screening RA and SpA in France and used in Serbia and Lithuania. MATERIAL AND METHODS: The study was performed in two steps. In step I, the French questionnaire was translated into Turkish and validated through a group of 200 patients (80 males, 120 females; mean age 44.0±13.1 years; range 19 to 75 years) followed up at the rheumatology departments of University Hospitals in Antalya and Ankara. In step II, the validated Turkish questionnaire was administered face-to-face to randomly selected 4,012 subjects (1,670 males, 2,342 females; mean age 41.5±16.8 years; range 16 to 97 years) by trained general practitioners across the country, in 25 prov- inces for case detection. The subjects who were suspected of having RA or SpA in accordance with the questionnaire were invited to the nearest university hospital for rheumatologic examination in order to confirm the diagnosis. RESULTS: In step II, a total of 25 subjects (2 males, 23 females) were diagnosed as RA. The standardized RA prevalence for the general population of Turkey was calculated as 0.56% (95% confidence interval [CI]; 0.33-0.79), 0.10% (95% CI; -0.05-0.25) for males and 0.89% (95% CI; 0.51-1.27) for females. A total of 18 subjects (3 males, 15 females) were diagnosed as SpA. The standardized SpA prevalence for the general population of Turkey was 0.46% (95% CI; 0.25-0.67), 0.17% (95% CI; -0.03-0.37) for males and 0.65% (95% CI; 0.32-0.98) for females. The prevalence of RA was highest in the Northern region (2.00%) and the prevalence of SpA was highest in the Central region (1.49%). CONCLUSION: The prevalences of RA and SpA in Turkey are close to each other and there are significant inter-regional variations in prevalences of both RA and SpA.
OBJECTIVES: This study aims to estimate the prevalence of rheumatoid arthritis (RA) and spondyloarthritis (SpA) in Turkey using the same telephone questionnaire developed for screening RA and SpA in France and used in Serbia and Lithuania. MATERIAL AND METHODS: The study was performed in two steps. In step I, the French questionnaire was translated into Turkish and validated through a group of 200 patients (80 males, 120 females; mean age 44.0±13.1 years; range 19 to 75 years) followed up at the rheumatology departments of University Hospitals in Antalya and Ankara. In step II, the validated Turkish questionnaire was administered face-to-face to randomly selected 4,012 subjects (1,670 males, 2,342 females; mean age 41.5±16.8 years; range 16 to 97 years) by trained general practitioners across the country, in 25 prov- inces for case detection. The subjects who were suspected of having RA or SpA in accordance with the questionnaire were invited to the nearest university hospital for rheumatologic examination in order to confirm the diagnosis. RESULTS: In step II, a total of 25 subjects (2 males, 23 females) were diagnosed as RA. The standardized RA prevalence for the general population of Turkey was calculated as 0.56% (95% confidence interval [CI]; 0.33-0.79), 0.10% (95% CI; -0.05-0.25) for males and 0.89% (95% CI; 0.51-1.27) for females. A total of 18 subjects (3 males, 15 females) were diagnosed as SpA. The standardized SpA prevalence for the general population of Turkey was 0.46% (95% CI; 0.25-0.67), 0.17% (95% CI; -0.03-0.37) for males and 0.65% (95% CI; 0.32-0.98) for females. The prevalence of RA was highest in the Northern region (2.00%) and the prevalence of SpA was highest in the Central region (1.49%). CONCLUSION: The prevalences of RA and SpA in Turkey are close to each other and there are significant inter-regional variations in prevalences of both RA and SpA.
Authors: A Saraux; F Guillemin; P Guggenbuhl; C H Roux; P Fardellone; E Le Bihan; A Cantagrel; I Chary-Valckenaere; L Euller-Ziegler; R-M Flipo; R Juvin; J-M Behier; B Fautrel; C Masson; J Coste Journal: Ann Rheum Dis Date: 2005-04-07 Impact factor: 19.103
Authors: S Hukuda; M Minami; T Saito; H Mitsui; N Matsui; Y Komatsubara; H Makino; T Shibata; M Shingu; T Sakou; K Shichikawa Journal: J Rheumatol Date: 2001-03 Impact factor: 4.666
Authors: C Kaçar; E Gilgil; T Tuncer; B Bütün; S Urhan; V Arikan; U Dündar; M C Oksüz; G Sünbüloğlu; C Yildirim; I Tekeoğlu; G Yücel Journal: Clin Rheumatol Date: 2004-11-13 Impact factor: 2.980
Authors: Mirjana I Zlatković-Švenda; Roksanda M Stojanović; Sandra B Šipetić-Grujičić; Francis Guillemin Journal: Rheumatol Int Date: 2013-11-29 Impact factor: 2.631
Authors: M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero Journal: Arthritis Rheum Date: 1991-10